Assessing Treatment Outcomes in Achalasia Using 4-Dimensional High-resolution Impedance Manometry.

IF 3.3 3区 医学 Q2 CLINICAL NEUROLOGY
Meng Li, Panyavee Pitisuttithum, Eric Goudie, Dustin A Carlson, John E Pandolfino, Wenjun Kou
{"title":"Assessing Treatment Outcomes in Achalasia Using 4-Dimensional High-resolution Impedance Manometry.","authors":"Meng Li, Panyavee Pitisuttithum, Eric Goudie, Dustin A Carlson, John E Pandolfino, Wenjun Kou","doi":"10.5056/jnm24170","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aims: </strong>Assessment of treatment response of achalasia often involves multiple procedures. We aim to investigate innovative metrics based on 4-dimensional high-resolution impedance manometry (4D HRM) to assess treatment response in achalasia patients.</p><p><strong>Methods: </strong>Patients with achalasia treated by pneumatic dilation or myotomy who underwent follow-up evaluations were included. All patients completed high-resolution impedance manometry before and after treatment. 4D HRM analysis based on developed python program measured clearance ratio, intrabolus pressure (IBP), maximum esophagogastric junction diameter, and distensibility index. Good treatment outcomes were defined as barium column height of < 5 cm at 5 minutes on timed barium esophagram (TBE) and Eckardt score ≤ 3.</p><p><strong>Results: </strong>Fifty-three patients with achalasia were included: 40% type I, 51% type II, and 9% type III. Change of clearance ratio and IBP on 4D HRM had superior performance in predicting abnormal TBE at 5 minutes (area under the receiver operating characteristic [AUROC] curve, 95% confidence interval: 0.76, 0.59-0.93; 0.74, 0.57-0.92). The combination of clearance ratio (increase with a threshold of 0.1) and IBP (reduction with a threshold of 8.9 mmHg) had a high positive predictive value for normal TBE outcome (93%), and a modest negative predictive value for abnormal TBE outcome (73%). Receiver operating characteristics of metrics related to poor symptomatic outcome only yielded AUROCs (95% CI) of 0.82 (0.68-0.96) for esophageal hypervigilance and anxiety scale posttreatment.</p><p><strong>Conclusions: </strong>IBP and clearance ratio help to identify abnormal barium retention in patients after treatment. 4D manometry can be an alternative or complementary approach to characterize and assess treatment response of Achalasia, in additional to TBE or functional lumen imaging probe.</p>","PeriodicalId":16543,"journal":{"name":"Journal of Neurogastroenterology and Motility","volume":"31 3","pages":"347-356"},"PeriodicalIF":3.3000,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12241924/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neurogastroenterology and Motility","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5056/jnm24170","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background/aims: Assessment of treatment response of achalasia often involves multiple procedures. We aim to investigate innovative metrics based on 4-dimensional high-resolution impedance manometry (4D HRM) to assess treatment response in achalasia patients.

Methods: Patients with achalasia treated by pneumatic dilation or myotomy who underwent follow-up evaluations were included. All patients completed high-resolution impedance manometry before and after treatment. 4D HRM analysis based on developed python program measured clearance ratio, intrabolus pressure (IBP), maximum esophagogastric junction diameter, and distensibility index. Good treatment outcomes were defined as barium column height of < 5 cm at 5 minutes on timed barium esophagram (TBE) and Eckardt score ≤ 3.

Results: Fifty-three patients with achalasia were included: 40% type I, 51% type II, and 9% type III. Change of clearance ratio and IBP on 4D HRM had superior performance in predicting abnormal TBE at 5 minutes (area under the receiver operating characteristic [AUROC] curve, 95% confidence interval: 0.76, 0.59-0.93; 0.74, 0.57-0.92). The combination of clearance ratio (increase with a threshold of 0.1) and IBP (reduction with a threshold of 8.9 mmHg) had a high positive predictive value for normal TBE outcome (93%), and a modest negative predictive value for abnormal TBE outcome (73%). Receiver operating characteristics of metrics related to poor symptomatic outcome only yielded AUROCs (95% CI) of 0.82 (0.68-0.96) for esophageal hypervigilance and anxiety scale posttreatment.

Conclusions: IBP and clearance ratio help to identify abnormal barium retention in patients after treatment. 4D manometry can be an alternative or complementary approach to characterize and assess treatment response of Achalasia, in additional to TBE or functional lumen imaging probe.

Abstract Image

Abstract Image

使用四维高分辨率阻抗测压法评估失弛缓症的治疗效果。
背景/目的:贲门失弛缓症治疗反应的评估通常涉及多个程序。我们的目的是研究基于四维高分辨率阻抗测压法(4D HRM)的创新指标来评估贲门失弛缓症患者的治疗反应。方法:对经气动扩张或肌切开术治疗的贲门失弛缓症患者进行随访评价。所有患者在治疗前后均完成高分辨率阻抗测压。基于开发的python程序进行4D HRM分析,测量清除率、肠内压(IBP)、食管胃交界最大直径和膨胀性指数。食管定时钡餐造影(TBE) 5分钟时钡餐柱高度< 5 cm, Eckardt评分≤3分为治疗效果良好。结果:纳入53例贲门失弛缓症患者:40%为I型,51%为II型,9%为III型。4D HRM清除率和IBP的变化对预测5分钟TBE异常有较好的效果(受试者工作特征曲线下面积,95%置信区间:0.76,0.59-0.93;0.74, 0.57 - -0.92)。清除率(增加阈值为0.1)和IBP(降低阈值为8.9 mmHg)的组合对正常TBE结果具有很高的阳性预测值(93%),对异常TBE结果具有适度的阴性预测值(73%)。治疗后食管高警觉性和焦虑量表的受试者操作特征与不良症状结局相关指标的auroc (95% CI)仅为0.82(0.68-0.96)。结论:IBP和清除率有助于鉴别治疗后患者钡潴留异常。除了TBE或功能性管腔成像探针外,4D测压可以作为表征和评估失弛缓症治疗反应的替代或补充方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Neurogastroenterology and Motility
Journal of Neurogastroenterology and Motility GASTROENTEROLOGY & HEPATOLOGY-CLINICAL NEUROLOGY
CiteScore
6.30
自引率
8.80%
发文量
96
期刊介绍: Journal of Neurogastroenterology and Motility (J Neurogastroenterol Motil) is a joint official journal of the Korean Society of Neurogastroenterology and Motility, the Thai Neurogastroenterology and Motility Society, the Japanese Society of Neurogastroenterology and Motility, the Indian Motility and Functional Disease Association, the Chinese Society of Gastrointestinal Motility, the South East Asia Gastro-Neuro Motility Association, the Taiwan Neurogastroenterology and Motility Society and the Asian Neurogastroenterology and Motility Association, launched in January 2010 after the title change from the Korean Journal of Neurogastroenterology and Motility, published from 1994 to 2009.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信